Cantargia AB logo

CANTA BTA - Cantargia AB Share Price

SEK7.34 0.0  0.0%

Last Trade - 11/01/18

Small Cap
Market Cap £186.6m
Enterprise Value £143.1m
Revenue £n/a
Position in Universe th / 1782
Unlock CANTA BTA Revenue
Relative Strength (%)
1m +16.2%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000 780
Balance Sheet
FINANCIAL BRIEF: : For the three months ended 31 March 2020, Cantargia AB revenues was not reported. Net loss increased 70% to SEK40M. Higher net loss reflects Research and Development Costs increase of 75% to SEK36.1M (expense), Administrative costs increase of 22% to SEK3.4M (expense), Interest expense and similar items increase from SEK0K to SEK456K (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -SEK0.36 to -SEK0.49.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


CANTA BTA Revenue Unlock CANTA BTA Revenue

Net Income

CANTA BTA Net Income Unlock CANTA BTA Revenue

Normalised EPS

CANTA BTA Normalised EPS Unlock CANTA BTA Revenue

PE Ratio Range

CANTA BTA PE Ratio Range Unlock CANTA BTA Revenue

Dividend Yield Range

CANTA BTA Dividend Yield Range Unlock CANTA BTA Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CANTA BTA EPS Forecasts Unlock CANTA BTA Revenue
Profile Summary

Cantargia AB is a Sweden-based company engaged in development of antibody therapeutics for the treatment of leukemia. The Company is engaged in the development of a therapy for the treatment of cancer by targeting a cell-surface receptor on malignant stem cells, through the development of antibody therapeutics for eradication of malignant stem cells. Cantargia AB uses the Interleukin-1 receptor accessory protein (IL1RAP), as the target for development of a novel antibody-based therapy for leukemia.

Last Annual December 31st, 2019
Last Interim March 31st, 2020
Public Since March 17, 2015
No. of Shareholders: 5,406
No. of Employees: 14
Sector Healthcare
Industry Biotechnology & Medical Research
Exchange OMX Nordic Exchange Stockholm (Dual Listing)
Shares in Issue 91,005,489
Free Float (0.0%)
Eligible for
CANTA BTA Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for CANTA BTA
Upcoming Events for CANTA BTA
Frequently Asked Questions for Cantargia AB
What is the Cantargia AB share price?

As of 11/01/18, shares in Cantargia AB are trading at SEK7.34, giving the company a market capitalisation of £186.6m. This share price information is delayed by 15 minutes.

How has the Cantargia AB share price performed this year?

Shares in Cantargia AB are currently trading at SEK7.34 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Cantargia AB price has moved by % over the past year.

What are the analyst and broker recommendations for Cantargia AB?

There are no analysts currently covering Cantargia AB.

When will Cantargia AB next release its financial results?

Cantargia AB is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the Cantargia AB dividend yield?

Cantargia AB does not currently pay a dividend.

Does Cantargia AB pay a dividend?

Cantargia AB does not currently pay a dividend.

When does Cantargia AB next pay dividends?

Cantargia AB does not currently pay a dividend.

How do I buy Cantargia AB shares?

To buy shares in Cantargia AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Cantargia AB?

Shares in Cantargia AB are currently trading at SEK7.34, giving the company a market capitalisation of £186.6m.

Where are Cantargia AB shares listed? Where are Cantargia AB shares listed?

Here are the trading details for Cantargia AB:

Country of listing: Sweden
Exchange: STO
Ticker Symbol: CANTA BTA
What kind of share is Cantargia AB?

We were not able to load our ranking data for Cantargia AB

Is there a Cantargia AB share price forecast 2020?

We were not able to load any forecast data for Cantargia AB.

How can I tell whether the Cantargia AB share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cantargia AB. Over the past six months, the relative strength of its shares against the market has been 36.01%. At the current price of SEK7.34, shares in Cantargia AB are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Cantargia AB PE Ratio?

We were not able to find PE ratio data for Cantargia AB.

Who are the key directors of Cantargia AB?

Cantargia AB's management team is headed by:

Thoas Fioretos - DRC
Claus Andersson - DRC
Goran Forsberg - CEO
Liselotte Larsson - COO
Lars Thorsson - VPR
David Liberg - VPR
Karin Leandersson - DRC
Magnus Persson - CHM
Bengt Jondell - CFO
Patricia Delaite - DRC
Anders Martin-Lof - DRC
Ignacio Garcia-Ribas - OTH
Who are the major shareholders of Cantargia AB?

Here are the top five shareholders of Cantargia AB based on the size of their shareholding:

Similar to CANTA BTA
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.